DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo-Reference-Cited by-同舟云学术

DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo

Published:2021-11 Issue:2 Volume:163 Page:334-341
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Tymon-Rosario Joan,Bonazzoli Elena,Bellone Stefania,Manzano Aranzazu,Pelligra Silvia,Guglielmi Adele,Gnutti Barbara,Nagarkatti Nupur,Zeybek Burak,Manara Paola,Zammataro Luca,Harold Justin,Mauricio Dennis,Buza Natalia,Hui Pei,Altwerger Gary,Menderes Gulden,Ratner Elena,Clark Mitchell,Andikyan Vaagn,Huang Gloria S.,Silasi Dan-Arin,Azodi Masoud,Schwartz Peter E.,Santin Alessandro D.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference41 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Cancer statistics, 2019;Siegel;CA Cancer J. Clin.,2019

3. Two pathogenetic types of endometrial carcinoma;Bokhman;Gynecol. Oncol.,1983

4. Factors associated with type I and type II endometrial cancer;Felix;Cancer Causes Control,2010

5. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases;Slomovitz;Gynecol. Oncol.,2003

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer;Cancer Medicine;2024-09

2. Research progress of antibody–drug conjugates in gynecologic cancer;Holistic Integrative Oncology;2024-08-29

3. Monoclonal Antibodies and Antibody-drug Conjugates as Emerging Therapeutics for Breast Cancer Treatment;Current Drug Delivery;2024-08

4. Entering the golden age for antibody-drug conjugates in gynecologic cancer;Oncoscience;2024-05-20

5. Implementation of antibody-drug conjugates in HER2-positive solid cancers: Recent advances and future directions;Biomedicine & Pharmacotherapy;2024-05